T helper type 1 cytokines and keratinocyte growth factor play a critical role in pseudoepitheliomatous hyperplasia initiation during cutaneous leishmaniasis

Archives of Dermatological Research

Volumn 299, Issue 7, 2007, Pages 315-325

  Akilov, Oleg E ^a,b   Donovan, Michael J ^a   Stepinac, Thomas ^b   Carter, Cristina R ^a   Whitcomb, James P ^a   Hasan, Tayyaba ^b   McDowell, Mary Ann ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cytokine; Growth factor; Hyperplasia; Keratinocyte; Leishmaniasis

Indexed keywords

CYTOKINE; GAMMA INTERFERON; KERATINOCYTE GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BASEMENT MEMBRANE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DERMIS; FEMALE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LEISHMANIA MAJOR; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOEPITHELIOMATOUS HYPERPLASIA; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN LEISHMANIASIS; TH1 CELL;

ANIMALS; COLLAGEN; EPIDERMIS; EPITHELIAL CELLS; FEMALE; FIBROBLAST GROWTH FACTOR 7; HYPERPLASIA; INTERFERON TYPE II; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED BALB C; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34548014297     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-007-0765-6     Document Type: Article

References (67)

1. Ackerman AB, Guo Y, Lazova R, Kaddu S (2001) Differential diagnosis in dermatopahtology II. Aldor Scribendi, New York City
2. Alexander J, Bryson K (2005) T helper (h)1/Th2 and Leishmania: paradox rather than paradigm. Immunol Lett 99:17-23
3. Bard JW (1981) Chondrodermatitis nodularis chronica helicis. Dermatologica 163:376-384
4. Barnes PJ, Karin M (1997) Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071
5. Berger MS, Gullick WJ, Greenfield C, Evans S, Addis BJ, Waterfield MD (1987) Epidermal growth factor receptors in lung tumours. J Pathol 152:297-307
6. Breuckmann F, Von Kobyletzki G, Avermaete A, Kreuter A, Altmeyer P (2002) Efficacy of ultraviolet A1 phototherapy on the expression of bcl-2 in atopic dermatitis and cutaneous T-cell lymphoma in vivo: a comparison study. Photodermatol Photoimmunol Photomed 18:217-222
7. Calcagni E, Elenkov I (2006) Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases. Ann N Y Acad Sci 1069:62-76
8. Courville P, Wechsler J, Thomine E et al (1999) Pseudoepitheliomatous hyperplasia in cutaneous T-cell lymphoma. A clinical, histopathological and immunohistochemical study with particular interest in epithelial growth factor expression. The French Study Group on Cutaneous Lymphoma. Br J Dermatol 140:421-426
9. Crane IJ, Forrester JV (2005) Th1 and Th2 lymphocytes in autoimmune disease. Crit Rev Immunol 25:75-102
10. Dabelsteen S, Wandall HH, Gron B, Dabelsteen E (1997) Keratinocyte growth factor mRNA expression in periodontal ligament fibroblasts. Eur J Oral Sci 105:593-598
11. Das SJ, Olsen I (2000) Keratinocyte growth factor is upregulated by the hyperplasia-inducing drug nifedipine. Cytokine 12:1566-1569
12. Das SJ, Newman HN, Olsen I (2002) Keratinocyte growth factor receptor is up-regulated in cyclosporin A-induced gingival hyperplasia. J Dent Res 81:683-687
13. Duncan MR, Berman B (1985) Gamma interferon is the lymphokine and beta interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation. J Exp Med 162:516-527
14. Ellis DL, Kafka SP, Chow JC et al (1987) Melanoma, growth factors, acanthosis nigricans, the sign of Leser-Trelat, and multiple acrochordons. A possible role for alpha-transforming growth factor in cutaneous paraneoplastic syndromes. N Engl J Med 317:1582-1587
15. Ellis DL, King LE Jr, Nanney LB (1992) Increased epidermal growth factor receptors in melanocytic lesions. J Am Acad Dermatol 27:539-546
16. Farrell CL, Rex KL, Chen JN et al (2002) The effects of keratinocyte growth factor in preclinical models of mucositis. Cell Prolif 35(Suppl 1):78-85
17. Finch PW, Rubin JS, Miki T, Ron D, Aaronson SA (1989) Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science 245:752-755
18. Fransson J (2000) Tumour necrosis factor-alpha does not influence proliferation and differentiation of healthy and psoriatic keratinocytes in a skin-equivalent model. Acta Derm Venereol 80:416-420
19. Ghosh AK, Yuan W, Mori Y, Chen S, Varga J (2001) Antagonistic regulation of type I collagen gene expression by interferon-gamma and transforming growth factor-beta. Integration at the level of p300/CBP transcriptional coactivators. J Biol Chem 276:11041-11048
20. Gottlieb SL, Gilleaudeau P, Johnson R et al (1995) Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat Med 1:442-447
21. Groves RW, Allen MH, MacDonald DM (1992) Abnormal expression of epidermal growth factor receptor in cutaneous epithelial tumours. J Cutan Pathol 19:66-72
22. Groves RW, Allen MH, Ross EL, Barker JN, MacDonald DM (1995) Tumour necrosis factor alpha is pro-inflammatory in normal human skin and modulates cutaneous adhesion molecule expression. Br J Dermatol 132:345-352
23. Grunwald MH, Lee JY, Ackerman AB (1988) Pseudocarcinomatous hyperplasia. Am J Dermatopathol 10:95-103
24. Habibi GR, Khamesipour A, McMaster WR, Mahboudi F (2001) Cytokine gene expression in healing and non-healing cases of cutaneous leishmaniasis in response to in vitro stimulation with recombinant gp63 using semi-quantitative RT-PCR. Scand J Immunol 54:414-420
25. Hayman JA, Smith IM, Flood P (1996) Pseudoepitheliomatous hyperplasia in Mycobacterium ulcerans infection. Pathology 28:131-134
26. Howard JG, Liew FY (1984) Mechanisms of acquired immunity in leishmaniasis. Philos Trans R Soc Lond B Biol Sci 307:87-98
27. Jiang B, Xu S, Brecher P, Cohen RA (2002) Growth factors enhance interleukin-1Cyrillic capital letter YA sign-induced persistent activation of nuclear factor-kB in rat vascular smooth muscle cells. Artertioscler Thromb Vasc Biol 22:1811-1816
28. Ju DM (1967) Pseudoepitheliomatous hyperplasia of the skin. Dermatol Int 6:82-92
29. Keen CE (1996) Combined skin lesions. Am J Dermatopathol 18:527-532
30. Kindler V, Sappino AP, Grau GE, Piguet PF, Vassalli P (1989) The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56:731-740
31. Kock A, Schwarz T, Kirnbauer R et al (1990) Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 172:1609-1614
32. Koos RD, Banks PK, Inkster SE, Yue W, Brodie AM (1993) Detection of aromatase and keratinocyte growth factor expression in breast tumors using reverse transcription-polymerase chain reaction. J Steroid Biochem Mol Biol 45:217-225
33. Krasne DL, Warnke RA, Weiss LM (1988) Malignant lymphoma presenting as pseudoepitheliomatous hyperplasia. A report of two cases. Am J Surg Pathol 12:835-842
34. Krishnan J, Tomaszewski MM, Kao GF (1993) Primary cutaneous CD30-positive anaplastic large cell lymphoma. Report of 27 cases. J Cutan Pathol 20:193-202
35. Krueger JG, Wolfe JT, Nabeya RT et al (1995) Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells. J Exp Med 182:2057-2068
36. Larrick JW, Morhenn V, Chiang YL, Shi T (1989) Activated Langerhans cells release tumor necrosis factor. J Leukoc Biol 45:429-433
37. Maas-Szabowski N, Stark HJ, Fusenig NE (2000) Keratinocyte growth regulation in defined organotypic cultures through IL-1-induced keratinocyte growth factor expression in resting fibroblasts. J Invest Dermatol 114:1075-1084
38. McGarvey TW, Stearns ME (1995) Keratinocyte growth factor and receptor mRNA expression in benign and malignant human prostate. Exp Mol Pathol 63:52-62
39. Mehregan AH (1968) Elastosis perforans serpiginosa: a review of the literature and report of 11 cases. Arch Dermatol 97:381-393
40. Morgan MB, Howard HG, Everett MA (1997) Epithelial induction in dermatofibroma: a role for the epidermal growth factor (EGF) receptor. Am J Dermatopathol 19:35-40
41. Nanney LB, Stoscheck CM, Magid M, King LE Jr (1986) Altered [125I]epidermal growth factor binding and receptor distribution in psoriasis. J Invest Dermatol 86:260-265
42. Nazmi MN, Dykes PJ, Marks R (1990) Epidermal growth factor receptors in human epidermal tumours. Br J Dermatol 123:153-161
43. Nickoloff BJ, Karabin GD, Barker JN et al (1991) Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis. Am J Pathol 138:129-140
44. Nicolis GD, Tosca AD, Stratigos JD, Capetanakis JA (1978) A clinical and histological study of cutaneous leishmaniasis. Acta Derm Venereol 58:521-525
45. Peters N, Sacks D (2006) Immune privilege in sites of chronic infection: Leishmania and regulatory T cells. Immunol Rev 213:159-179
46. Pierce GF, Yanagihara D, Klopchin K et al (1994) Stimulation of all epithelial elements during skin regeneration by keratinocyte growth factor. J Exp Med 179:831-840
47. Pober JS, Cotran RS (1990) Cytokines and endothelial cell biology. Physiol Rev 70:427-451
48. Puchtler H, Waldrop FS, Valentine LS (1973) Polarization microscopic studies of connective tissue stained with picro-sirius red FBA. Beitrage zur Pathologie 150:174-187
49. Putrino I, Baccarini P, Bracko M, Foschini MP, Collina G (1998) Malignant melanoma with pseudoepitheliomatous reaction marker. A case report. Pathologica 90:397-402
50. Rauch BH, Weber A, Braun M, Zimmermann N, Schror K (2000) PDGF-induced Akt phosphorylation does not activate NF-kappa B in human vascular smooth muscle cells and fibroblasts. FEBS Lett 481:3-7
51. Regueiro M, Valentine J, Plevy S, Fleisher MR, Lichtenstein GR (2003) Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease. Am J Gastroenterol 98:1821-1826
52. Rubin JS, Osada H, Finch PW, Taylor WG, Rudikoff S, Aaronson SA (1989) Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci USA 86:802-806
53. Sacks D, Anderson C (2004) Re-examination of the immunosuppressive mechanisms mediating non-cure of Leishmania infection in mice. Immunol Rev 201:225-238
54. Scarisbrick JJ, Calonje E, Orchard G, Child FJ, Russell-Jones R (2001) Pseudocarcinomatous change in lymphomatoid papulosis and primary cutaneous CD30+ lymphoma: a clinicopathologic and immunohistochemical study of 6 patients. J Am Acad Dermatol 44:239-247
55. Scott G, Chen KT, Rosai J (1989) Pseudoepitheliomatous hyperplasia in Spitz nevi. A possible source of confusion with squamous cell carcinoma. Arch Pathol Lab Med 113:61-63
56. Spath GF, Beverley SM (2001) A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation. Exp Parasitol 99:97-103
57. Speirs K, Caamano J, Goldschmidt MH, Hunter CA, Scott P (2002) NF-kappa B2 is required for optimal CD40-induced IL-12 production but dispensable for Th1 cell Differentiation. J Immunol 168:4406-4413
58. Staiano-Coico L, Krueger JG, Rubin JS et al (1993) Human keratinocyte growth factor effects in a porcine model of epidermal wound healing. J Exp Med 178:865-878
59. Takeda Y, Sasou S, Obata K (1998) Pleomorphic adenoma of the minor salivary gland with pseudoepitheliomatous hyperplasia of the overlying oral mucosa: report of two cases. Pathol Int 48:389-395
60. Tang A, Gilchrest BA (1996) Regulation of keratinocyte growth factor gene expression in human skin fibroblasts. J Dermatol Sci 11:41-50
61. Vallat VP, Gilleaudeau P, Battat L et al (1994) PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: a possible cellular basis for remittive therapy. J Exp Med 180:283-296
62. Victor FC, Gottlieb AB, Menter A (2003) Changing paradigms in dermatology: tumor necrosis factor alpha (TNF-alpha) blockade in psoriasis and psoriatic arthritis. Clin Dermatol 21:392-397
63. Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF (1991) Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci USA 88:4220-4224
64. Werner S, Smola H, Liao X et al (1994) The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. Science 266:819-822
65. Werner S (1998) Keratinocyte growth factor: a unique player in epithelial repair processes. Cytokine Growth Factor Rev 9:153-165
66. White C, Weidman FD (1927) Pseudoepitheliomatous hyperplasia at the margins of cutanous ulcers. J Am Med Assoc 88:1595-1963
67. Wilmer JL, Luster MI (1995) Chemical induction of interleukin-8, a proinflammatory chemokine, in human epidermal keratinocyte cultures and its relation to cytogenetic toxicity. Cell Biol Toxicol 11:37-50